Publications by authors named "P Chaudhari"

Objectives: Outpatient follow-up visits are often recommended for children with ambulatory care-sensitive conditions (ACSCs) who are discharged from emergency departments or urgent care centers (acute care settings). We sought to assess whether attending a follow-up visit within 7 days is associated with seeking initial office-based care rather than acute care during a subsequent ACSC illness. Understanding this association is crucial to guide recommendations for routine short-term follow-up visits in children who seek acute care for these common conditions.

View Article and Find Full Text PDF

Objectives: The development and progression of chronic heart failure (CHF), hypertrophy, and remodeling strongly correlate with myocardial inflammation and oxidative stress. S-adenosylmethionine (SAMe), available as a dietary supplement, exerts anti-inflammatory and antioxidant effects. Previous reports show that by regulating angiogenesis and fibrosis, S-adenosyl-L-methionine improves ventricular remodeling.

View Article and Find Full Text PDF

It is well documented that aging elicits metabolic failures, while poor metabolism contributes to accelerated aging. Metabolism in general, and energy metabolism in particular are also effective entry points for interventions that extend lifespan and improve organ function during aging. In this review, we discuss common metabolic remedies for healthy aging from the angle of their potential age-specificity.

View Article and Find Full Text PDF
Article Synopsis
  • Availability of large medical datasets is hindered by privacy laws, which complicates machine learning applications in disease diagnosis and treatment.
  • GenMIND is introduced as a solution, offering generative models based on over 40,000 MRI scans that consider factors like age, sex, and race.
  • The system generates 18,000 synthetic brain MRI samples that improve machine learning model accuracy for tasks like disease classification, and both the dataset and models are publicly accessible.
View Article and Find Full Text PDF
Article Synopsis
  • * USFDA-approved drugs that block VEGFR2 face issues like drug resistance and heart-related side effects, highlighting the need for safer and more effective treatments.
  • * The review discusses recent findings on the structure and function of VEGFR2 inhibitors, including crucial molecular interactions and design requirements for developing new cancer therapies.
View Article and Find Full Text PDF